Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis.

Mohme M, Hotz C, Stevanovic S, Binder T, Lee JH, Okoniewski M, Eiermann T, Sospedra M, Rammensee HG, Martin R.

Brain. 2013 Jun;136(Pt 6):1783-98. doi: 10.1093/brain/awt108.

2.

T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.

Vergelli M, Kalbus M, Rojo SC, Hemmer B, Kalbacher H, Tranquill L, Beck H, McFarland HF, De Mars R, Long EO, Martin R.

J Neuroimmunol. 1997 Aug;77(2):195-203.

PMID:
9258250
3.

High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model.

Ellmerich S, Mycko M, Takacs K, Waldner H, Wahid FN, Boyton RJ, King RH, Smith PA, Amor S, Herlihy AH, Hewitt RE, Jutton M, Price DA, Hafler DA, Kuchroo VK, Altmann DM.

J Immunol. 2005 Feb 15;174(4):1938-46.

4.

Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.

Sospedra M, Muraro PA, Stefanov√° I, Zhao Y, Chung K, Li Y, Giulianotti M, Simon R, Mariuzza R, Pinilla C, Martin R.

J Immunol. 2006 Feb 1;176(3):1951-61.

5.
6.

DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).

Kaushansky N, Altmann DM, David CS, Lassmann H, Ben-Nun A.

J Neuroinflammation. 2012 Feb 8;9:29. doi: 10.1186/1742-2094-9-29.

7.

Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.

Valli A, Sette A, Kappos L, Oseroff C, Sidney J, Miescher G, Hochberger M, Albert ED, Adorini L.

J Clin Invest. 1993 Feb;91(2):616-28.

8.

HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype.

Prat E, Tomaru U, Sabater L, Park DM, Granger R, Kruse N, Ohayon JM, Bettinotti MP, Martin R.

J Neuroimmunol. 2005 Oct;167(1-2):108-19.

PMID:
16111772
9.

A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.

Madsen LS, Andersson EC, Jansson L, krogsgaard M, Andersen CB, Engberg J, Strominger JL, Svejgaard A, Hjorth JP, Holmdahl R, Wucherpfennig KW, Fugger L.

Nat Genet. 1999 Nov;23(3):343-7.

PMID:
10610182
11.

Tumor rejection effects of allorestricted tumor peptide-specific CD4(+) T cells on human cervical cancer cell xenograft in nude mice.

Song Y, Sun W, Weng X, Liang Z, Yu Q, Wang Z, Ouyang L, Chen J, Wu X, Shen G, Wu X.

Cell Transplant. 2012;21(7):1503-14.

PMID:
22525838
12.

Properties of HLA class II molecules divergently associated with Goodpasture's disease.

Phelps RG, Jones V, Turner AN, Rees AJ.

Int Immunol. 2000 Aug;12(8):1135-43.

13.
14.

Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.

Harfouch-Hammoud E, Walk T, Otto H, Jung G, Bach JF, van Endert PM, Caillat-Zucman S.

Diabetes. 1999 Oct;48(10):1937-47.

PMID:
10512357
15.

Month of birth is associated with multiple sclerosis but not with HLA-DR15 in Finland.

Saastamoinen KP, Auvinen MK, Tienari PJ.

Mult Scler. 2012 May;18(5):563-8. doi: 10.1177/1352458511426814. Epub 2011 Oct 31.

PMID:
22041092
16.

[Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases].

Nishimura Y.

Nihon Rinsho. 1997 Jun;55(6):1384-96. Review. Japanese.

PMID:
9200922
17.

Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.

Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.

J Neuroimmunol. 2005 Feb;159(1-2):155-64. Epub 2004 Dec 28.

PMID:
15652415
18.

T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects.

Trotter JL, Pelfrey CM, Trotter AL, Selvidge JA, Gushleff KC, Mohanakumar T, McFarland HF.

J Neuroimmunol. 1998 Apr 15;84(2):172-8.

PMID:
9628460
19.

Molecular analyses of HLA class II-associated susceptibility to subtypes of autoimmune diseases unique to Asians.

Nishimura Y, Kanai T, Oiso M, Tabata H, Ito H, Kira J, Chen YZ, Matsushita S.

Int J Cardiol. 1998 Oct 1;66 Suppl 1:S93-104; discussion S105. Review.

PMID:
9951808
Items per page

Supplemental Content

Write to the Help Desk